• Views: in the last
  • 19Week
  • 9Month
  • 161Total

  • NJ A4320
  • Requires health insurers, SHBP and SEHBP to provide coverage for digital tomosynthesis for screening and diagnostic purposes related to breast cancer.
In Committee
Crossed OverPassedSignedDead/Failed/Vetoed
2016-2017 Regular Session
This bill requires health insurers and health maintenance organizations, as well as health benefits plans or contracts which are issued or purchased pursuant to the New Jersey Individual Health Coverage Program, New Jersey Small Employer Health Benefits Program, State Health Benefits Program, and School Employees' Health Benefits Program, to provide coverage for expenses incurred in conducting digital tomosynthesis to detect or screen for breast cancer in women 40 years of age and over; and for diagnostic purposes in women of any age. Digital tomosynthesis, also sometimes called 3-D mammography, creates a three-dimensional picture of the breast using x-rays. Several low-dose images from different angles around the breast are used to create the final 3-D picture. Conventional mammography produces one image of overlapping tissue, while tomosynthesis provides multiple pictures of breast tissue as the scanner moves in an arc. The difference between the images produced by tomosynthesis and conventional mammography has been described as being akin to a ball (three dimensional) versus a circle (flat).
2nd Reading in the Assembly, Financial Institutions and Insurance, Substituted by another Bill
Substituted by S2793 (1R)  (on 1/8/2018)
Date Chamber Action Description
1/8/2018 A Substituted by S2793 (1R)
3/16/2017 A Assembly Floor Amendment Passed (Chiaravalloti)
12/5/2016 A Reported out of Assembly Committee, 2nd Reading
12/5/2016 Assembly Financial Institutions and Insurance Hearing (10:00 12/5/2016 Committee Room 16, Fourth Floor)
11/14/2016 A Introduced, Referred to Assembly Financial Institutions and Insurance Committee
Date Motion Yea Nay Other
Detail 12/5/2016 Assembly Financial Institutions and Insurance Committee: Reported Favorably 13 0 0